rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2005-5-2
|
pubmed:abstractText |
Previous studies have demonstrated reductions of serotonin 5-HT 2A receptors in the neocortex of Alzheimer's disease (AD) patients. However, it is unclear whether such losses play a role in the cognitive decline of AD.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0033-3158
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
179
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
673-7
|
pubmed:dateRevised |
2010-3-23
|
pubmed:meshHeading |
pubmed-meshheading:15551121-Aged,
pubmed-meshheading:15551121-Aged, 80 and over,
pubmed-meshheading:15551121-Alzheimer Disease,
pubmed-meshheading:15551121-Cognition Disorders,
pubmed-meshheading:15551121-Female,
pubmed-meshheading:15551121-Humans,
pubmed-meshheading:15551121-Longitudinal Studies,
pubmed-meshheading:15551121-Male,
pubmed-meshheading:15551121-Protein Binding,
pubmed-meshheading:15551121-Receptor, Serotonin, 5-HT2A,
pubmed-meshheading:15551121-Temporal Lobe
|
pubmed:year |
2005
|
pubmed:articleTitle |
Loss of serotonin 5-HT2A receptors in the postmortem temporal cortex correlates with rate of cognitive decline in Alzheimer's disease.
|
pubmed:affiliation |
Dementia Research Laboratory, Department of Clinical Research, Singapore General Hospital, Outram Road, 169608, Singapore.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|